Pew Health Group to ensure safety of U.S. drug supply

On Wednesday, September 14, Allan Coukell, a pharmacist and director of medical programs at the Pew Health Group, will testify before the Senate Health Education Labor and Pensions Committee about the need for Congressional action to ensure the safety of the U.S. drug supply.

Nearly 80 percent of all pharmaceutical ingredients now originate outside the U.S. Increasingly, Americans rely on pharmaceuticals that are produced in foreign manufacturing facilities, many in developing countries where there is less regulatory oversight. The law needs to be updated to keep up with increasingly outsourced drug manufacturing.

As part of the reauthorization of the Prescription Drug User Fee Act (PDUFA), Congress should focus on addressing risks to the U.S. drug supply.

WHAT: Senate Health Education Labor and Pensions Committee hearing, entitled "Securing the Pharmaceutical Supply Chain"

WHEN: Wednesday, September 14, 2011, 10:00 A.M. ET

WHERE: Health, Education, Labor & Pensions Committee Room, SD-430

WHO: Allan Coukell, director of medical programs, Pew Health Group

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How virtual reality transforms women’s labor experiences